n INTRODUCTION H yperuricemia is the metabolic abnormality underlying gout, an inflammation of the joints that was already recognized by the ancient Greeks (e.g. Hippocrates and his aphorisms on gout, 5th century BC). Gout has continued to fascinate physicians and scientists over the centuries. The link with hyperuricemia as the underlying metabolic abnormality started with the identification of uric acid in 1776, and progressed through to the famous "thread test" that Garrod used in 1848 to demonstrate that blood in gouty patients contained significant quantities of urate. In 1961, McCarty and Hollander published their observations that crystals obtained from the joints of gout patients were composed of monosodium urate (1) . For many, the clinical problem of gout and its treatment would appear to be solved. However, to our surprise, the subject is still proving to be a rewarding topic for clinical investigation, and recent research has led to a renewal of interest in the mechanisms underlying the metabolic abnormality, as well as possible links between hyperuricemia and cardiovascular and metabolic disorders. Calcium pyrophosphate (CPP) deposition occurs mainly in joint cartilage and intervertebral disc, specifically in hyaline and fibro-cartilage. In order to clarify and to provide a uniform definition of CPP deposition (CPPD) disease, the European League Against Rheumatism (EULAR) task force has recently compiled two sets of recommendations concerning first the diagnosis and terminology, and second the management of the disease (2, 3) . Thus, CPPD is the umbrella term for all instances of CPP crystal occurrence, and chondrocalcinosis (CC) means cartilage calcification,
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The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis) identified by imaging or histological examination. CC is not always due to CPPD and may occur as an isolated finding in an apparently otherwise normal joint, or coexist with structural changes resembling osteoarthritis. Several types and dimensions of CPP crystals have been identified in synovial fluid (SF) including monoclinic and triclinic dihydrated CPP crystals (m-CPP and t-CPP: Ca 2 P 2 O 7 , 2H 2 O) (4). Although often asymptomatic, CPP crystal deposition can be associated with osteoarthritis, acute mono-or oligo-articular arthritis and, more rarely, chronic polyarthritis and destructive arthropathy (2). Acute mono-or oligo-articular arthritis secondary to CPP crystal deposition can mimic gout attacks and has, therefore, been initially referred to as pseudogout. Interestingly, both MSU and CPP crystal-induced inflammation resolve themselves spontaneously. Last but not least, based on the discovery of the inflammasome and of its activation by MSU and CPP crystals, research has produced new treatments that may be of great relevance to patients suffering from gout, and eventually also pseudogout. , inorganic phosphate (Pi), and inorganic pyrophosphate (PPi). Extracellular PPi is produced either de novo through the extracellular metabolism of nucleotides or originates from the release of intracellular PPi (7) . The concentration of extracellular PPi depends chiefly on four proteins: membrane glycoprotein-1 or PC-1, tissue non-specific alkaline phosphatase (ALP), the PPi transmembrane transporter ANK and CD73 protein (7, 8) . Extracellular PPi concentration is increased by PC-1, ANK and CD73 and decreased by ALP, which hydrolyzes PPi. PC-1, ANK and ALP expression is modulated by cytokines and growth factors, as well as by Pi and PPi ions. Thus, TGF-β increases ANK expression and CPP crystal formation (9), whereas insulin growth factor-1 has the opposite effect (10) . Similarly, intracellular PPi decreases the transcription of both ANK and PC-1 mRNAs, whereas Pi has the opposite effect (6) .
The cells interacting and responding to crystals are leukocytes, in particular neutrophils and macrophages, but also endothelial cells, synoviocytes and mast cells (11, 12) . Resident macrophages are of particular interest, as they have been reported to play a role in initiating the tissue response to MSU in a mouse peritonitis model (13) . Mast cells also deserve a mention, as in the peritonitis model of gout, depletion of peritoneal mast cells attenuated the neutrophil inflammatory response (14) . Finally, resident macrophages and mast cells are able to release IL-1β upon crystal activation of the NALP3 inflammasome (see below). These results suggest that these cells par- Experimental evidence is available which shows a role for TLR2 and TLR4 in MSU recognition by monocyte/macrophages, as the presence of TLR2 and TLR4 exacerbated MSU crystal-induced IL-1β production and PMN recruitment in the murine air pouch model (16) . Similarly, CPP and MSU crystals trigger nitric oxide production through TLR-2 activation in articular chondrocytes (17) . However, these results should be viewed with caution since another group found that none of the known TLRs were essential in the murine peritonitis model (18) . A second mechanism may involve a direct interaction between crystals and cell membrane leading to intracellular signaling cascades. Indeed, atomic force microscopy has shown that specific interaction of MSU crystals with dendritic cell membrane occurs (19) . This interaction led to activation of the tyrosine kinase Syk that might mediate either internalization of the crystal or a cellular response to the binding of the crystal (20, 21 Proinflammatory cytokines undoubtedly play a critical role in orchestrating the inflammatory reaction to MSU crystals. Recent attention has focused in particular on the role of IL-1β. IL-1β is the prototypic inflammatory cytokine and exerts different types of action on cells and tissues. The cytokine is produced as an inactive promolecule by immune cells such as macrophages, monocytes and dendritic cells, and is then cleaved into the active p17 form of IL-1β to be secreted out of the cell. Cleavage of pro-IL-1β is catalyzed by caspase-1 (also known as IL-1-converting enzyme, ICE). Caspase-1 is a member of the family of inflammatory caspases that include caspase-4, caspase-5, caspase-11 and caspase-12; in the context of IL-1β processing, caspase-1 accounts for the main activity that requires the formation of a molecular platform known as the inflammasome review
The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis) (28) . Other pathways of IL-1β processing independent of caspase-1 have been described, implicating neutrophil-derived and mast cell-derived proteases (29, 30) . The NLRP3 inflammasome is a cytoplasmic protein complex composed of NLRP3, a protein of the NLRP (or NALP) family, an adapter ASC protein as well as the inflammatory caspase-1. The ASC adapter contains a PYD domain that mediates interaction with a homologous domain on NLRP, as well as a CARD domain that interacts with caspase-1 ( Figure 1 ). . These cells will produce inflammatory cytokines and chemokines such as iL1β, iL8 and MCP-1, which in turn will activate endothelial cells (which will then start to express e-selectin) and stimulate monocyte and polymorphonuclear neutrophil cell (PNN) infiltrate (step 2). infiltrating cells will also contribute to further iL-1β and iL-8 secretion (step 3) thereby amplifying the inflammatory reaction by recruiting additional inflammatory cells (step 4). Figure 2 . In a study published in 2010, Joosten et al. provide important new insights into the mechanisms underlying gout inflammation (30) . It is known that patients can have MSU deposits that are clinically quiescent, indicating that there is further regu- Figure 2 -Crystal activation of the NLrP3 inflammasome. NLrP3 or cryopyrin is composed of three distict domains (NACHT-Lrr-PYD domains) and belongs to the NOD-like receptors involved in innate immunity. The inflammasome, formed by NLrP3 (NLrP3 inflammasome), binds to ASC (apoptosis-associated speck-like protein containing a CArD). ASC in turn will bind to caspase-1 (Cas-1), previously known as interleukin-converting enzyme (iCe). Different mechanisms are involved in the inflammasome activation: direct crystal interaction with the cell membrane and subsequent tyrosine kinase Syk activation; crystal interaction with cell membrane receptors such as TLr (Toll-like receptor) and phagocytosis of crystals. Upon phagocytosis, crystals induce K+ efflux via ATP binding to P2X7r, reactive oxygen species (rOS) generation and lysosomal damage (probably via cathepsin B release). These events lead to NLrP3 inflammasome activation. The resulting autocatalytic activation of caspase-1 then induces pro-iL1β (Mw 35 kD) cleavage into biologically active iL-1β (Mw 17 kD). Although Syk kinase activation is independent of inflamamsome activation, lysosomal damage may be a common step for both pathways. Finally, there is as yet no evidence for CPP crystal binding and Syk activation. The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis) lation at the level of the tissue response to urate crystals. It is important to underline here that reports claiming that MSU crystals are potent inducers of IL-1β production have been performed in cell lines that were pre-activated with PMA or LPS. Such pre-activation is necessary for the induction of both IL-1β mRNA and pro IL-1β. In experiments using pure MSU alone, no cytokine was released. It was convincingly demonstrated that free fatty acids C18:0 acting on Toll-like receptor 2 (TLR-2) can synergize with MSU crystals in order to induce inflammasome activation and cytokine release. This demonstrates that the release of FFAs after food ingestion or alcohol consumption represents the "missing link" between metabolic changes, inflammasome activation, and gout attacks (30) .
n MeChaNISMS SeCONDaRy TO Il-1β ReleaSe
We have seen above that, through a series of steps that are still not well understood, MSU crystals activate the NLRP3 inflammasome of phagocytes, resulting in processing and secretion of IL-1β. The subsequent recruitment of inflammatory leukocytes to the site, most probably mediated by endothelial activation, can account for the subsequent release of inflammatory mediators and the recognized inflammatory manifestations of acute gout ( Figure 1 ). Although crystals have been shown to induce multiple cytokines and chemokines that promote gouty inflammation, including tumor necrosis factor-α (TNF-α), IL-6, CXC-chemokine ligand (CXCL) 1 and CXCL8 (also known as IL-8), it has been suggested that these are produced in a hierarchical manner, secondary to IL-1β release. For instance, in experimental MSUinduced inflammation, IL-1β has a more central role than TNF-α (32). Nevertheless, in different experimental settings, a role for CXCL8 has been clearly demonstrated in both CPP and MSU crystal-induced inflammation (33) (34) (35) .
Mechanisms underlying spontaneous resolution of acute inflammation
Despite the rapid onset and the severity of crystal-associated inflammation, there is a self-limiting factor in the gout crisis and a return ad integrum of the affected joint. The first explanation provided for the resolution of inflammation is the nature of the coating of the crystals. Indeed, it was shown that crystals coated with IgG fragments were more inflammatory than naked crystals (36) , whereas crystals coated with ApoB and ApoE could contribute in part to the resolution of acute gouty arthritis (37) . Another mechanism involved in the resolution of microcrystal-induced arthritis flares involves the physiological transformation of monocyte into macrophage. Indeed, when macrophages were differentiated in vitro, they became less proinflammatory in their response to MSU crystals, even though they retained their capacity for phagocytosis (38) . The difference in the cellular response seems also to be linked to the state of the macrophage and the phenotypic variations of macrophages (M1 and M2 macrophages) (39) . The "switch" monocyte-macrophage has been observed during gout flare resolution and is associated not only with a decrease in the synthesis of proinflammatory cytokines (IL-1, IL-6, TNF-α), but also with an increased production of anti-inflammatory cytokines (IL-10 and TGF-β) (40) . Hence macrophages start to produce TGF-β, a key cytokine in this anti-inflammatory process (41) . This TGF-β can thus reduce endothelial cell activation, thus limiting PNN and monocyte recruitment and also cytokine expression, such as IL-1 and its receptor. In addition TGF-β secretion is stimulated by macrophagic clearance of apoptotic neutrophils. In this context it should be noted that apoptotic neutrophil clearance can be favored by type 2 transglutaminase (42). In conclusion, the autoregulation of inflammation by phagocytes together with differential coating of MSU crystals may explain the selflimiting nature of acute gout, as well as the fact that the presence of MSU crystals in a joint is not always accompanied by inflammatory response n RefeReNCeS
